Literature DB >> 15143187

Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity.

Lawrence S Argetsinger1, Jean-Louis K Kouadio, Hanno Steen, Allan Stensballe, Ole N Jensen, Christin Carter-Su.   

Abstract

The tyrosine kinase JAK2 is a key signaling protein for at least 20 receptors in the cytokine/hematopoietin receptor superfamily and is a component of signaling by insulin receptor and several G-protein-coupled receptors. However, there is only limited knowledge of the physical structure of JAK2 or which of the 49 tyrosines in JAK2 are autophosphorylated. In this study, mass spectrometry and two-dimensional peptide mapping were used to determine that tyrosines 221, 570, and 1007 in JAK2 are autophosphorylated. Phosphorylation of tyrosine 570 is particularly robust. In response to growth hormone, JAK2 was rapidly and transiently phosphorylated at tyrosines 221 and 570, returning to basal levels by 60 min. Analysis of the sequences surrounding tyrosines 221 and 570 in JAK2 and tyrosines in other proteins that are phosphorylated in response to ligands that activate JAK2 suggests that the YXX[L/I/V] motif is one of the motifs recognized by JAK2. Experiments using JAK2 with tyrosines 221 and 570 mutated to phenylalanine suggest that tyrosines 221 and 570 in JAK2 may serve as regulatory sites in JAK2, with phosphorylation of tyrosine 221 increasing kinase activity and phosphorylation of tyrosine 570 decreasing kinase activity and thereby contributing to rapid termination of ligand activation of JAK2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15143187      PMCID: PMC416404          DOI: 10.1128/MCB.24.11.4955-4967.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

1.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

2.  Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain.

Authors:  A Sasaki; H Yasukawa; A Suzuki; S Kamizono; T Syoda; I Kinjyo; M Sasaki; J A Johnston; A Yoshimura
Journal:  Genes Cells       Date:  1999-06       Impact factor: 1.891

3.  JAK2, a third member of the JAK family of protein tyrosine kinases.

Authors:  A G Harpur; A C Andres; A Ziemiecki; R R Aston; A F Wilks
Journal:  Oncogene       Date:  1992-07       Impact factor: 9.867

4.  Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor.

Authors:  S J Frank; W Yi; Y Zhao; J F Goldsmith; G Gilliland; J Jiang; I Sakai; A S Kraft
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

5.  The conserved box 1 motif of cytokine receptors is required for association with JAK kinases.

Authors:  J W Tanner; W Chen; R L Young; G D Longmore; A S Shaw
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

6.  Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase.

Authors:  L S Argetsinger; G S Campbell; X Yang; B A Witthuhn; O Silvennoinen; J N Ihle; C Carter-Su
Journal:  Cell       Date:  1993-07-30       Impact factor: 41.582

7.  Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells.

Authors:  T Murata; P D Noguchi; R K Puri
Journal:  J Biol Chem       Date:  1995-12-22       Impact factor: 5.157

8.  Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals.

Authors:  U Klingmüller; U Lorenz; L C Cantley; B G Neel; H F Lodish
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

9.  The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony-stimulating factor receptor beta c chain.

Authors:  Y Zhao; F Wagner; S J Frank; A S Kraft
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

10.  Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity.

Authors:  F Gouilleux; C Pallard; I Dusanter-Fourt; H Wakao; L A Haldosen; G Norstedt; D Levy; B Groner
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

View more
  50 in total

Review 1.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

2.  Androgen receptor exon 1 mutation causes androgen insensitivity by creating phosphorylation site and inhibiting melanoma antigen-A11 activation of NH2- and carboxyl-terminal interaction-dependent transactivation.

Authors:  William H Lagarde; Amanda J Blackwelder; John T Minges; Andrew T Hnat; Frank S French; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

3.  Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependent.

Authors:  Rita Andraos; Zhiyan Qian; Débora Bonenfant; Joëlle Rubert; Eric Vangrevelinghe; Clemens Scheufler; Fanny Marque; Catherine H Régnier; Alain De Pover; Hugues Ryckelynck; Neha Bhagwat; Priya Koppikar; Aviva Goel; Lorenza Wyder; Gisele Tavares; Fabienne Baffert; Carole Pissot-Soldermann; Paul W Manley; Christoph Gaul; Hans Voshol; Ross L Levine; William R Sellers; Francesco Hofmann; Thomas Radimerski
Journal:  Cancer Discov       Date:  2012-05-03       Impact factor: 39.397

Review 4.  Molecular and neural mediators of leptin action.

Authors:  Scott A Robertson; Gina M Leinninger; Martin G Myers
Journal:  Physiol Behav       Date:  2008-04-13

5.  CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms.

Authors:  Sara C Meyer; Matthew D Keller; Sophia Chiu; Priya Koppikar; Olga A Guryanova; Franck Rapaport; Ke Xu; Katia Manova; Dmitry Pankov; Richard J O'Reilly; Maria Kleppe; Anna Sophia McKenney; Alan H Shih; Kaitlyn Shank; Jihae Ahn; Eftymia Papalexi; Barbara Spitzer; Nick Socci; Agnes Viale; Emeline Mandon; Nicolas Ebel; Rita Andraos; Joëlle Rubert; Ernesta Dammassa; Vincent Romanet; Arno Dölemeyer; Michael Zender; Melanie Heinlein; Raajit Rampal; Rona Singer Weinberg; Ronald Hoffman; William R Sellers; Francesco Hofmann; Masato Murakami; Fabienne Baffert; Christoph Gaul; Thomas Radimerski; Ross L Levine
Journal:  Cancer Cell       Date:  2015-07-13       Impact factor: 31.743

6.  Phosphorylation of Y372 is critical for Jak2 tyrosine kinase activation.

Authors:  Jacqueline Sayyah; Kavitha Gnanasambandan; Sushama Kamarajugadda; Shigeharu Tsuda; Jennifer Caldwell-Busby; Peter P Sayeski
Journal:  Cell Signal       Date:  2011-06-29       Impact factor: 4.315

7.  Thermal injury of the skin induces G-CSF-dependent attenuation of EPO-mediated STAT signaling and erythroid differentiation arrest in mice.

Authors:  John G Noel; Benjamin J Ramser; Jose A Cancelas; Francis X McCormack; Jason C Gardner
Journal:  Exp Hematol       Date:  2017-09-01       Impact factor: 3.084

8.  JAK2S523L, a novel gain-of-function mutation in a critical autoregulatory residue in JAK2V617F- MPNs.

Authors:  Friederike Pastore; Aishwarya Krishnan; Henrik M Hammarén; Olli Silvennoinen; Benedict Yan; Ross L Levine
Journal:  Blood Adv       Date:  2020-09-22

9.  Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity.

Authors:  Megumi Funakoshi-Tago; Stéphane Pelletier; Hiroshi Moritake; Evan Parganas; James N Ihle
Journal:  Mol Cell Biol       Date:  2007-12-26       Impact factor: 4.272

10.  Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells.

Authors:  Xiuting Chen; Zhe Ying; Xi Lin; Huanxin Lin; Jueheng Wu; Mengfeng Li; Libing Song
Journal:  J Clin Invest       Date:  2013-05-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.